Get the ChemPriceHub app — track prices on the go. Membership syncs across app & web. View plans
We value your privacy
We use cookies and similar technologies to enhance your browsing experience, analyze site traffic, and deliver personalized content. You can choose to accept or reject non-essential cookies. Read our Privacy Notice.

Cookie Preferences

Manage your cookie preferences. Essential cookies are always enabled for the site to function. You can change your choice at any time via the "Cookie Settings" link in the footer. Read our Privacy Notice for full details.

Essential Cookies

Required for basic site functionality, including anti-spam protection and session management. Always active.

Analytics Cookies

Help us understand how visitors interact with the site. We use Google Analytics to improve our service. Disabling this will not affect essential functionality.

Welcome to ChemPriceHub

 
Home > News > ChemPriceHub Alert: Acrylonitrile Prices at High Levels, Losses Improve

ChemPriceHub Alert: Acrylonitrile Prices at High Levels, Losses Improve

Published on 2026-02-05

This week, acrylonitrile prices remained relatively high, leading to an improvement in production losses. According to statistics, as of February 5, the average production cost of acrylonitrile in China was 8,600 yuan/ton, up 0.34% month-on-month. During the same period, the average production profit of acrylonitrile was -820 yuan/ton, an increase of 271 yuan/ton month-on-month. PriceSeek analysis of acrylonitrile, with a bullish-bearish score of 1: Acrylonitrile prices remain high, and production losses improved by 271 yuan/ton month-on-month to -820 yuan/ton, indicating strong market demand support and improved corporate profitability, which provides favorable support for spot prices. The production cost increased slightly by 0.34% month-on-month to 8,600 yuan/ton, indicating that cost pressure on the supply side is manageable. However, overall profits remain negative, and subsequent supply-demand changes need to be monitored.

Comments

0
No comments yet.